Quince Therapeutics (QNCX) Short Interest Ratio & Short Volume → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free QNCX Stock Alerts $0.90 -0.01 (-1.09%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Quince Therapeutics Short Interest DataCurrent Short Volume1,970,000 sharesPrevious Short Volume1,860,000 sharesChange Vs. Previous Month+5.91%Dollar Volume Sold Short$2.11 millionShort Interest Ratio / Days to Cover26.7Last Record DateApril 30, 2024Outstanding Shares43,220,000 sharesFloat Size29,940,000 sharesShort Percent of Float6.58%Today's Trading Volume227,354 sharesAverage Trading Volume95,726 sharesToday's Volume Vs. Average238% Short Selling Quince Therapeutics ? Sign up to receive the latest short interest report for Quince Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatQNCX Short Interest Over TimeQNCX Days to Cover Over TimeQNCX Percentage of Float Shorted Over Time Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Quince Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,970,000 shares $2.11 million +5.9%6.6%26.7 $1.07 4/15/20241,860,000 shares $1.87 million No Change6.2%26.8 $1.01 3/31/20241,860,000 shares $1.97 million No Change6.2%26.9 $1.06 3/15/20241,860,000 shares $2.16 million -2.1%6.3%26.4 $1.16 2/29/20241,900,000 shares $2.47 million No Change6.4%22.6 $1.30 2/15/20241,900,000 shares $2.47 million No Change6.4%20.3 $1.30 Get the Latest News and Ratings for QNCX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Quince Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,900,000 shares $2.36 million -7.3%6.0%20.9 $1.24 1/15/20242,050,000 shares $2.81 million -8.1%6.4%23.2 $1.37 12/31/20232,230,000 shares $2.34 million +16.2%6.9%29.1 $1.05 12/15/20231,920,000 shares $2.27 million -10.7%6.0%18.8 $1.18 11/30/20232,150,000 shares $1.91 million -1.4%6.2%23.2 $0.89 11/15/20232,180,000 shares $1.94 million +0.9%6.3%24 $0.89 10/31/20232,160,000 shares $2.10 million -8.1%6.5%20.3 $0.97 10/15/20232,350,000 shares $2.33 million +0.4%8.3%16.1 $0.99 9/30/20232,340,000 shares $2.62 million -2.1%8.2%7.7 $1.12 9/15/20232,390,000 shares $2.99 million -1.7%8.5%8.6 $1.25 8/31/20232,430,000 shares $3.18 million -6.5%8.6%8.7 $1.31 8/15/20232,600,000 shares $3.30 million -9.7%9.2%9.3 $1.27 7/31/20232,880,000 shares $3.46 million -10.8%10.0%10.5 $1.20 7/15/20233,230,000 shares $5.26 million No Change11.5%12.3 $1.63 6/30/20233,230,000 shares $4.86 million -0.9%11.3%23.8 $1.51 6/15/20233,260,000 shares $4.89 million +2.5%11.4%15.3 $1.50 5/31/20233,180,000 shares $4.77 million +5.3%11.1%2.9 $1.50 5/15/20233,020,000 shares $4.65 million No Change10.6%2.7 $1.54 QNCX Short Interest - Frequently Asked Questions What is Quince Therapeutics' current short interest? Short interest is the volume of Quince Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 1,970,000 shares of QNCX short. 6.58% of Quince Therapeutics' shares are currently sold short. Learn More on Quince Therapeutics' current short interest. What is a good short interest ratio for Quince Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. QNCX shares currently have a short interest ratio of 27.0. Learn More on Quince Therapeutics's short interest ratio. What is a good short interest percentage for Quince Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.58% of Quince Therapeutics' floating shares are currently sold short. Is Quince Therapeutics' short interest increasing or decreasing? Quince Therapeutics saw a increase in short interest in April. As of April 30th, there was short interest totaling 1,970,000 shares, an increase of 5.9% from the previous total of 1,860,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Quince Therapeutics' float size? Quince Therapeutics currently has issued a total of 43,220,000 shares. Some of Quince Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Quince Therapeutics currently has a public float of 29,940,000 shares. How does Quince Therapeutics' short interest compare to its competitors? 6.58% of Quince Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Quince Therapeutics: MiNK Therapeutics, Inc. (0.88%), Estrella Immunopharma, Inc. (0.12%), Cyclo Therapeutics, Inc. (0.35%), SAB Biotherapeutics, Inc. (0.30%), Achilles Therapeutics plc (0.06%), OKYO Pharma Limited (0.43%), Pluri Inc. (0.97%), Dyadic International, Inc. (0.96%), Brainstorm Cell Therapeutics Inc. (3.00%), Surrozen, Inc. (2.15%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Quince Therapeutics stock? Short selling QNCX is an investing strategy that aims to generate trading profit from Quince Therapeutics as its price is falling. QNCX shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Quince Therapeutics? A short squeeze for Quince Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of QNCX, which in turn drives the price of the stock up even further. How often is Quince Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including QNCX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: INKT Short Interest Data ESLA Short Interest Data CYTH Short Interest Data SABS Short Interest Data ACHL Short Interest Data OKYO Short Interest Data PLUR Short Interest Data DYAI Short Interest Data BCLI Short Interest Data SRZN Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:QNCX) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaWhat’s Really Next for America…Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersProtect Your Bank Account Before It’s Too LateWeiss RatingsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society